Ken Griffin Pasithea Therapeutics Corp Wt Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pasithea Therapeutics Corp Wt stock. As of the latest transaction made, Citadel Advisors LLC holds 15,511 shares of KTTAW stock, worth $310. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,511
Holding current value
$310
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$0.01 - $0.03 $155 - $465
15,511 New
15,511 $0
Q2 2024

Aug 14, 2024
SELL
$0.01 - $0.02 $0 - $0
-15 Reduced 0.11%
13,189 $0
Q1 2024

May 15, 2024
BUY
$0.0 - $0.02 $0 - $2
100 Added 0.76%
13,204 $0
Q4 2023

Feb 14, 2024
BUY
$0.0 - $0.02 $0 - $5
278 Added 2.17%
13,104 $0
Q3 2023

Nov 14, 2023
BUY
$0.01 - $0.07 $128 - $897
12,826 New
12,826 $0

Others Institutions Holding KTTAW

# of Institutions
5
Shares Held
400K
Call Options Held
0
Put Options Held
0
View Full List

About PASITHEA THERAPEUTICS CORP WT

KTTAW Quotes by TradingView
  • Ticker KTTAW
  • Sector Healthcare
  • Industry Biotechnology
More about KTTAW
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email